With every passing day, new discoveries are made that lend support to the increasing and important role biomarker analysis and tumor profiling play in personalized cancer care. Caris Life Sciences® is actively participating in research to advance the understanding of molecular science, further enabling the delivery of precision medicine.

Molecular profiling in a large cohort of gynecologic neuroendocrine tumors

Feasibility of a platform trial based on molecular analysis in rare gynecologic cancers

Differences in the molecular landscape of uterine cancer between African American and Caucasian patients

Comprehensive molecular profiling of IDH1/2 mutant biliary cancers (BC)

Molecular characterization of appendiceal goblet cell carcinoid

Molecular landscape of gastric cancer (GC) harboring mutations of histone methyltransferases

Non-urothelial bladder cancer genomic alterations and patient outcomes

Molecular Profiling of Aggressive Variant Urothelial Carcinoma

Tumor mutational burden (TMB) profile of K-RAS/TP-53 co-mutation in metastatic non-small cell lung cancer (m-NSCLC)

Molecular profiling of biliary cancers reveals distinct molecular alterations and potential therapeutic targets